VF
INM icon

Virtu Financial’s InMed Pharmaceuticals INM Stock Holding History

Virtu Financial’s Portfolio INM Stock Details INM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,980
Closed -$13K – 1907
2026
Q1 		$13K Buy
+19,980
New +$18.8K ﹤0.01% 1440
2025
Q4 		– Sell
-20,369
Closed -$45K – 1928
2025
Q3 		$45K Buy
+20,369
New +$49.1K ﹤0.01% 1148
2024
Q4 		– Sell
-1,421
Closed -$7K – 1775
2024
Q3 		$7K Sell
1,421
-2,913
-67% -$14.8K ﹤0.01% 1232
2024
Q2 		$23K Buy
+4,334
New +$24.8K ﹤0.01% 1014
2023
Q1 		– Sell
-886
Closed -$36K – 1772
2022
Q4 		$36K Buy
+886
New +$59.6K ﹤0.01% 1144
2021
Q4 		– Sell
-23
Closed -$20K – 1928
2021
Q3 		$20K Buy
+23
New +$27.4K ﹤0.01% 1382

Other funds holding INM

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
UFM
Ursa Fund Management Danville, California $1.28B AUM 89.08% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Virtu Financial's INM Position: Q2 2026 in Review

Virtu Financial sold out of InMed Pharmaceuticals (INM) in Q2 2026, closing a stake of 19,980 shares — an estimated $13K sold.

Virtu Financial first reported a position in INM in Q3 2021 and held it in 6 quarters. The position peaked at $45K in Q3 2025. 20 funds tracked by Wall St. Rank hold INM as of Q2 2026.

  • Virtu Financial reported no remaining InMed Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 19,980 InMed Pharmaceuticals shares in Q2 2026, an estimated $13K.
  • Virtu Financial first reported a position in InMed Pharmaceuticals in Q3 2021 and held it in 6 quarters.
  • Virtu Financial's InMed Pharmaceuticals position peaked at $45K in Q3 2025.
  • 20 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.